
Experts Issue New Treatment Algorithm for Chronic Rhinosinusitis with Nasal Polyps
YARDLEY, PA — Optinose (NASDAQ: OPTN), a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists, this …
Experts Issue New Treatment Algorithm for Chronic Rhinosinusitis with Nasal Polyps Read More